Palvella Therapeutics (PVLA) FCF Margin Growth (1y) (2015 - 2024)
Powered by 
Analysis
Palvella Therapeutics (PVLA) FCF Margin Growth (1y) (2015 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 26,102.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 869.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 769.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 811.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19,111.00 |
| 10 | Palvella Therapeutics | 2.24 Bn | 1.93 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -152,979.00 |
| Dec 31, 2023 | 179,610.00 |
| Sep 30, 2023 | 11,393.00 |
| Jun 30, 2023 | 37,106.00 |
| Mar 31, 2023 | -34,344.00 |
| Dec 31, 2022 | -8,737.00 |
| Sep 30, 2022 | 20,154.00 |
| Jun 30, 2022 | -134,167.00 |
| Mar 31, 2022 | -11,243.00 |
| Dec 31, 2021 | 61,193.00 |
| Sep 30, 2021 | -13,665.00 |
| Jun 30, 2021 | 99,979.00 |
| Mar 31, 2021 | 3,505.00 |
| Dec 31, 2020 | -65,788.00 |
| Sep 30, 2020 | -14,385.00 |
| Jun 30, 2020 | 12,241.00 |
| Mar 31, 2020 | 4,959.00 |
| Dec 31, 2019 | 151,611.00 |
| Sep 30, 2019 | 9,082.00 |
| Jun 30, 2019 | -13,854.00 |